Cargando…

Preclinical Evaluation of Oncolytic Δγ (1)34.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases

The metastasis of breast cancer to the brain and central nervous system (CNS) is a problem of increasing importance. As improving treatments continue to extend patient survival, the incidence of CNS metastases from breast cancer is on the rise. New treatments are needed, as current treatments are li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cody, James J., Scaturro, Pietro, Cantor, Alan B., Yancey Gillespie, G., Parker, Jacqueline N., Markert, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549352/ https://www.ncbi.nlm.nih.gov/pubmed/23346408 http://dx.doi.org/10.1155/2012/628697

Ejemplares similares

Chimeric HCMV/HSV-1 and Δγ(1)34.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory()()
por: Ghonime, Mohammed G., et al.
Publicado: (2017)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
por: Gillory, Lauren A., et al.
Publicado: (2013)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()
por: Waters, Alicia M., et al.
Publicado: (2016)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
por: Megison, Michael L., et al.
Publicado: (2014)

Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
por: Chiocca, E. Antonio, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
por: Cody, James J., et al.
Publicado: (2014)

Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
por: Cassady, Kevin A., et al.
Publicado: (2017)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
por: Yin, Jie, et al.
Publicado: (2017)

Oncolytic Herpes Simplex Virus Immunotherapy for Brain Tumors: Current Pitfalls and Emerging Strategies to Overcome Therapeutic Resistance
por: Totsch, Stacie K., et al.
Publicado: (2019)

The Herpes Simplex Virus Neurovirulence Factor γ34.5: Revealing Virus–Host Interactions
por: Wilcox, Douglas R., et al.
Publicado: (2016)

Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children
por: Cripe, Timothy P, et al.
Publicado: (2015)

Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors
por: Abdoli, Shahriyar, et al.
Publicado: (2017)

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children
por: Friedman, Gregory K, et al.
Publicado: (2015)

Herpes Simplex Virus γ34.5 Interferes with Autophagosome Maturation and Antigen Presentation in Dendritic Cells
por: Gobeil, Philipe A. M., et al.
Publicado: (2012)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Combination strategies enhance oncolytic virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2017)

Interplay between Autophagy and Herpes Simplex Virus Type 1: ICP34.5, One of the Main Actors
por: Ripa, Inés, et al.
Publicado: (2022)

Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016)

IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
por: Thomas, Eric D., et al.
Publicado: (2016)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
por: Ghose, Jayeeta, et al.
Publicado: (2021)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
por: Yura, Yoshiaki
Publicado: (2017)

The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
por: Nguyen, Hong-My, et al.
Publicado: (2021)

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
por: Hong, Bangxing, et al.
Publicado: (2022)

Targeting Pediatric Cancer Stem Cells with Oncolytic Virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2012)

Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
por: Eissa, Ibrahim Ragab, et al.
Publicado: (2017)

1679 Interactions of the Herpes Simplex Virus γ34.5 Protein With Host Signaling Pathways Influence Central Nervous System Disease in Newborn Mice
por: Wilcox, Douglas, et al.
Publicado: (2014)

Treatment of breast cancer stem cells with oncolytic herpes simplex virus
por: Li, J, et al.
Publicado: (2012)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
por: Menotti, Laura, et al.
Publicado: (2020)

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers
por: Scanlan, Hayle, et al.
Publicado: (2022)

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
por: Hu, Mingming, et al.
Publicado: (2023)

PI3-Kinase δγ Catalytic Isoforms Regulate the Th-17 Response in Tuberculosis
por: Leisching, Gina R.
Publicado: (2019)

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2013)

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
por: Chen, Xilin, et al.
Publicado: (2016)

Stability and anti-tumor effect of oncolytic herpes simplex virus type 2
por: Wang, Yang, et al.
Publicado: (2018)

Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
por: Boscheinen, Jan B., et al.
Publicado: (2019)

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
por: Cockle, Julia V., et al.
Publicado: (2017)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
por: Woo, Yanghee, et al.
Publicado: (2019)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
por: Bernstock, Joshua D., et al.
Publicado: (2021)

HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy
por: Li, H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i8fs1tmv83pakv5pk53fht179e